Seltzer V L, Molho L, Fougner A, Hong P, Kereszti B, Gero M, Spitzer M
Department of Obstetrics and Gynecology, Queens Hospital Center, Jamaica, New York 11432.
Gynecol Oncol. 1988 Jun;30(2):216-21. doi: 10.1016/0090-8258(88)90027-3.
In the world's literature, only 16 patients with parovarian malignancies have been described, five of which have been of low-malignant potential. All but one of these low-malignant potential lesions have been serous tumors. This is the second low-malignant potential parovarian tumor to be described with mucinous and serous components as well as hobnail cells. These tumors occur almost exclusively in young women, yet they are so rare that no treatment plan has been developed. We propose that until more data becomes available, these low-malignant potential lesions be treated as are their ovarian counterparts with staging laparotomy and surgery which conserves reproductive functioning being appropriate for women who meet the rigid clinical and histologic criteria for a very early potentially nonaggressive tumor, and complete extirpative surgery for those who do not.
在世界文献中，仅描述过16例副卵巢恶性肿瘤患者，其中5例为低恶性潜能肿瘤。这些低恶性潜能病变除1例之外均为浆液性肿瘤。这是第二例被描述的具有黏液性和浆液性成分以及鞋钉样细胞的低恶性潜能副卵巢肿瘤。这些肿瘤几乎仅发生于年轻女性，但极为罕见，以至于尚未制定出治疗方案。我们建议，在获得更多数据之前，这些低恶性潜能病变的治疗方式应与卵巢同类病变相同，即对于符合早期潜在非侵袭性肿瘤严格临床和组织学标准的女性，采用分期剖腹术和保留生殖功能的手术进行治疗，而对于不符合标准的女性，则进行彻底的切除手术。
